Novoderm Aps: Financial statements 2024
CVR: 42112747
Source: annual report 2024, Danish Business Authority
01/10/2023 – 30/09/2024
Novoderm Aps (CVR 42112747) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,340,363 and a net result of DKK 152,554 compared with DKK 272,276 the year before. That is an increase of 14.8% compared with the year before. Equity in the 2024 report amounted to DKK -728,782.
- Gross Profit
- DKK 1,340,363
- Profit/Loss
- DKK 152,554
- Equity
- DKK -728,782
- Total Assets
- DKK 475,442
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.3 mio. | 153 t. | -729 t. | - |
| 2023 | - | 1.2 mio. | 272 t. | -532 t. | 2 |
| 2022 | - | 465 t. | -329 t. | -755 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Novoderm Aps has published its annual report for 2023. Gross profit came to DKK 1,167,698, and the net result was DKK 272,276.
About Novoderm Aps
Novoderm Aps is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2021. The company is registered under the industry Speciallægers aktiviteter. The company was previously named Privatklinik Nomo Roskilde ApS. The management consists of Jeanette Svensson. The company is owned by Svensson Inc ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 2,045,973 and a net result of DKK 59,938 compared with DKK 152,554 the year before. Equity in the 2025 report amounted to DKK -668,845.